Scheinberg DA - Search Results

1

Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity.

Nikula TK, Bocchia M, Curcio MJ, Sgouros G, Ma Y, Finn RD, Scheinberg DA. Nikula TK, et al. Among authors: scheinberg da. Mol Immunol. 1995 Aug;32(12):865-72. doi: 10.1016/0161-5890(95)00052-g. Mol Immunol. 1995. PMID: 7565813

2

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.

Scheinberg DA. Scheinberg DA. Curr Opin Immunol. 1991 Oct;3(5):679-84. doi: 10.1016/0952-7915(91)90096-j. Curr Opin Immunol. 1991. PMID: 1661602 Review.

3

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, et al. Scheinberg DA, et al. J Clin Oncol. 1991 Mar;9(3):478-90. doi: 10.1200/JCO.1991.9.3.478. J Clin Oncol. 1991. PMID: 1999719 Clinical Trial.

4

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies.

Nikula TK, Curcio MJ, Brechbiel MW, Gansow OA, Finn RD, Scheinberg DA. Nikula TK, et al. Among authors: scheinberg da. Nucl Med Biol. 1995 Apr;22(3):387-90. doi: 10.1016/0969-8051(94)00126-5. Nucl Med Biol. 1995. PMID: 7627155

5

Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules.

Bocchia M, Wentworth PA, Southwood S, Sidney J, McGraw K, Scheinberg DA, Sette A. Bocchia M, et al. Among authors: scheinberg da. Blood. 1995 May 15;85(10):2680-4. Blood. 1995. PMID: 7742526 Free article.

6

Recent developments in the radioimmunotherapy of cancer.

Jurcic JG, Scheinberg DA. Jurcic JG, et al. Among authors: scheinberg da. Curr Opin Immunol. 1994 Oct;6(5):715-21. doi: 10.1016/0952-7915(94)90074-4. Curr Opin Immunol. 1994. PMID: 7826526 Review.

7

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.

Jurcic JG, Caron PC, Miller WH Jr, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP Jr, Scheinberg DA. Jurcic JG, et al. Among authors: scheinberg da. Leukemia. 1995 Feb;9(2):244-8. Leukemia. 1995. PMID: 7869759

8

Treatment of leukemia with radiolabeled monoclonal antibodies.

Sgouros G, Scheinberg DA. Sgouros G, et al. Among authors: scheinberg da. Cancer Treat Res. 1993;68:23-64. doi: 10.1007/978-1-4615-3076-3_3. Cancer Treat Res. 1993. PMID: 8105852 Review.

9

Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody.

Co MS, Scheinberg DA, Avdalovic NM, McGraw K, Vasquez M, Caron PC, Queen C. Co MS, et al. Among authors: scheinberg da. Mol Immunol. 1993 Oct;30(15):1361-7. doi: 10.1016/0161-5890(93)90097-u. Mol Immunol. 1993. PMID: 8232322

10

Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemia.

Caron PC, Schwartz MA, Co MS, Queen C, Finn RD, Graham MC, Divgi CR, Larson SM, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. Cancer. 1994 Feb 1;73(3 Suppl):1049-56. doi: 10.1002/1097-0142(19940201)73:3+<1049::aid-cncr2820731344>3.0.co;2-1. Cancer. 1994. PMID: 8306247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters